Drugs / 11C-Methionine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05608395 | Dec 2020 → Jun 2024 | glioblastoma | Masaryk Memorial Cancer Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-Methionine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05608395 ↗ |
| Modality | Diagnostic / imaging agent | “11C-Methionine is an example of a radiolabelled (carbon 11) amino acid commonly used in the diagnosis of brain tumors” PMID 38879476 ↗ Jun 2024 |